{"id":"W3137251658","doi":"10.1016/j.ctrv.2021.102187","title":"Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer Foundation; Merck KGaA; EMD Serono; Pfizer","keywords":"Avelumab; Medicine; Metastatic Urothelial Carcinoma; Carboplatin; Chemotherapy; Oncology; Internal medicine; Maintenance therapy; Cisplatin; Clinical trial; Bladder cancer; Javelin; Cancer; Immunotherapy; Nivolumab; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001914077,0.0005860991,0.002842734,0.001063892,0.0001248039,0.001211502,0.0009836012,0.000875597,0.004842024],"category_scores_gemma":[0.002688393,0.0002304885,0.001949446,0.001287076,0.0003015826,0.0007966399,0.0003685675,0.001716506,0.0006159225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006362534,"about_ca_system_score_gemma":0.001251244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001255597,"about_ca_topic_score_gemma":0.003612625,"domain_scores_codex":[0.9995975,0.0001529974,0.00008005363,0.000062495,0.00008178449,0.00002519919],"domain_scores_gemma":[0.998666,0.0009348516,0.0002270272,0.00002231064,0.000107246,0.00004246228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00129593,0.0001015175,0.000282956,0.09862004,0.00200317,0.0000746244,0.00004874415,0.0004101697,0.0009305442,0.001224353,0.01722892,0.8777791],"study_design_scores_gemma":[0.006661545,0.004355052,0.008360535,0.1317759,0.0222108,0.001316219,0.0002191216,0.0008196194,0.001473702,0.003371906,0.8193041,0.0001314645],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000283584,0.9990135,0.00005106637,0.0001715017,0.0001041476,0.0000138265,0.00003915932,0.000004969101,0.0003181362],"genre_scores_gemma":[0.002909877,0.9961655,0.0001806702,0.0003956961,0.00008007757,0.00002081924,0.00005266742,0.000002247845,0.0001925313],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004842024,"threshold_uncertainty_score":0.01619816,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3066253015532885,"score_gpt":0.5286651053873425,"score_spread":0.222039803834054,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}